The June 2012 International Society of Pediatric Neuro Oncology (ISPNO) meeting in Toronto, Canada featuried a Low Grade Glioma (LGG) Symposium. This was the third time the PLGA Foundation had sponsored a targeted session at ISPNO and interest in the low grade glioma field continues to grow amongst scientists and medical experts because of meeting such as these.

The ISPNO meets once every 2 years and attracts an international audience of over 1000 experts in the clinical and research fields. The exposure that this symposium gives to this disease is immense. The LGG session sold out in the first two weeks with over 200 participants registering. This means that more attention will be focused on the most common forms of children’s brain tumors giving hope to the children battling these tumors for more effective treatments and a cure.

The LGG Session was moderated by Dr. Charles Eberhart, Associate Professor of Oncology, Pathology and Opthomology at Johns Hopkins University School of Medicine, and was broken down into three sections discussing the most recent advancements in the following areas:

1) From lab discovery to clinical decision making

2) Platforms for drug discovery in PLGG (cell lines and mouse models)

3) Current and novel drug therapies for PLGG

For more information, please see the ISPNO program at http://ispno2012.com/program